Franck Touret

This study determines SARS-CoV-2 inactivation times on musical materials, showing variability based on porosity and composition, with non-porous surfaces clearing virus in 3 days and porous ones requiring up to 7 days.

This study evaluates a human liver spheroid model for antiviral drug testing against BSL-3 HFVs, finding that some viruses replicate in the model and antiviral compounds show activity with dose variations.

The paper identifies a mutation in dengue virus genomes from the 2023-2024 French Caribbean epidemic that confers resistance to the anti-dengue compound mosnodenvir.

The paper generates and evaluates SARS-CoV-2 mutants resistant to protease inhibitors nirmatrelvir and ensitrelvir, showing in vitro and in vivo resistance and linking M49L mutation prevalence to Xocova(R) use.